leisure time -WSS

leisure time

author：hotspot 2025-09-30 20:05:41 - browse：35945

Since the early days of the pandemic, long Covid has haunted us: Even a mild acute infection might leave you with life-altering consequences. And for many, that has, sadly, turned out to be the case. While research suggests long Covid rates are falling, it still affects millions. In June 2023, 6% of Americans reported experiencing long Covid.

But what if long Covid isn’t the right way to think about what they are going through?

On this episode of the First Opinion Podcast, I spoke with Steven Phillips and Michelle A. Williams, authors of a recent First Opinion essay titled, “Long Covid is a new name for an old syndrome.” Steven is a Global Virus Network board member and vice president for science and strategy at the COVID Collaborative; Michelle is the former dean and current Joan and Julius Jacobson professor of epidemiology and public health at the Harvard T.H. Chan School of Public Health.

“Michelle and I have come up with basically a new paradigm that says long Covid is really an old disease, and the more you do deep dives into the history of chronic fatigue syndrome and post-infectious fatigue syndromes, the more you realize that not only are there similarities, but the level of congruence between the two is strikingly high,” Steven said.

The purpose of this new paradigm is to “break the logjam” of the current long Covid discourse and “to try to provide a framework whereby people would think about long Covid in a different way in a way that would be more productive,” Michelle told me.

We discussed the history of post-infectious disease syndrome, what rethinking long Covid might mean for research, and the ways the health care system fails chronically ill patients.

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts.

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： AltruBio raises $225 million to develop ulcerative colitis drug

WSS

Plastic surgeons increase patient psychiatric screenings

Health AI adoption puts security, privacy startups on investors' radar

HHS's proposed rule does nothing to address the climate crisis

Empower primary care with adequate payments and technology

Future doctors should be trained to promote social change

Orchard's therapy for neuron disease in children wins FDA approval

Wikipedia

leisure time

hotspot

Apple is now the first public company to be valued at $3 trillion

U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

Walensky prepares to leave CDC — and Congress — behind

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

Peter Hotez and the public health issue of online harassment

The creative science of coining drug names

Anesthesiologist group: stop taking Ozempic before surgery

Leading voice in opioid treatment defends methadone clinic system

Apple is now the first public company to be valued at $3 trillion

5 to watch: Tech startups trying to solve health care's staffing crisis

knowledge

Class action alleges UnitedHealth concealed DOJ probe

As health system earnings go up, health insurance stocks go down

GSK’s asthma push continues as drug succeeds in Phase 3 trials

AstraZeneca to buy developer of next

Empower primary care with adequate payments and technology

Is it ever OK for doctors to lie to their patients?

explore

explore

hotspot

knowledge